Polar Asset Management Partners Inc. Cytokinetics Inc Transaction History

Polar Asset Management Partners Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $4.23 Million - $6.63 Million	-88,400 Reduced 95.77%	3,900 $211,000
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $5.88 Million - $9.97 Million	92,300 New	92,300 $6.47 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $6.21 Million - $7.76 Million	190,400 New	190,400 $6.21 Million
Q2 2022 Aug 15, 2022	SELL	$33.93 - $48.92 $2.8 Million - $4.04 Million	-82,600 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $924,015 - $1.25 Million	26,900 Added 48.29%	82,600 $3.77 Million
Q3 2021 Nov 15, 2021	SELL	$18.54 - $35.74 $2.16 Million - $4.16 Million	-116,400 Reduced 67.64%	55,700 $1.99 Million
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $3.41 Million - $4.64 Million	172,100 New	172,100 $3.41 Million

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.92B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.